Safety and Preliminary Efficacy of NXL-001 in Patients with Ischemic Stroke
Latest Information Update: 13 Jan 2025
Price :
$35 *
At a glance
- Drugs NXL-001 (Primary)
- Indications Stroke
- Focus Adverse reactions
- 13 Jan 2025 New trial record
Latest Information Update: 13 Jan 2025